Document is current
Any future updates will be listed below
-
Authors
Wang, Ping https://orcid.org/0000-0002-1395-2014
Wang, Min
Liu, Lin
Li, Hongyi
Liu, Helin
Ren, Jiangbo
Liu, Tianhui
Cong, Min
Zhu, Zhijun
Zhao, Xinyan
Sun, Liying
Jia, Jidong
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82370603, 81570548)
National Major Science and Technology Projects of China (2018ZX09201016)
- License Information
-
More Information
Article History
Received: 8 December 2023
Accepted: 26 August 2024
First Online: 11 September 2024
Declarations
:
: Liver tissues were obtained from the Clinical Data and Biobank Resource of Beijing Friendship Hospital with the approval of the Ethics Committee of Beijing Friendship Hospital, Capital Medical University. Title of the approved project: Exploration of the new markers for liver stem/progenitor cells in liver fibrotic tissues and tumors. Name of the institutional approval committee: the Ethics Committee of Beijing Friendship Hospital, Capital Medical University. Approval number: 2018‐P2‐055‐01. Date of approval: 8/3/2018. The animal experiments and procedures were approved by the Animal Experiments and Experimental Animal Welfare Committee of Capital Medical University. Title of the approved project: The safety and efficacy of targeting NPM1to treat liver tumours by promoting apoptosis of progenitor cells. Name of the institutional approval committee: Animal Experiments and Experimental Animal Welfare Committee of Capital Medical University. Approval number: AEEI-2024-036. Date of approval: 1/31/2024.
: Not applicable.
: The authors declare that they have no competing interests.
